Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics (Q43624603)

25 November 2017

title

Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics (English)

1 reference

25 November 2017

0 references

1 reference

Cimochowski GE

1

1 reference

25 November 2017

Harostock MD

2

1 reference

25 November 2017

Brown R

3

1 reference

25 November 2017

Bernardi M

4

1 reference

25 November 2017

Alonzo N

5

1 reference

25 November 2017

Coyle K

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

The Annals of Thoracic Surgery

25 November 2017

published in

1 reference

25 November 2017

volume

71

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

1572-8; discussion 1578-9

1 reference

Factors predisposing to median sternotomy complications. Deep vs superficial infection

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

The epidemiology of chest and leg wound infections following cardiothoracic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Risk factors for surgical-wound infection following cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Nasal staphylococci and sepsis in hospital patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Reduction of surgical site infections in major surgery by elimination of nasal carriage of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

The economic implications of infection in cardiac surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

The nose: an underestimated source of Staphylococcus aureus causing wound infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Glucose control lowers the risk of wound infection in diabetics after open heart operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902519-X

10.1016/S0003-4975(01)02519-X

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference